Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease

被引：0
|
作者：
Dennis B Holmgaard
Lone H Mygind
Ingrid L Titlestad
Hanne Madsen
Svend Stenvang Pedersen
Julia S Johansen
Court Pedersen
机构：
[1] Odense University Hospital,Department of Infectious Diseases Q
[2] Odense University Hospital,Department of Respiratory Medicine J
[3] Aalborg Hospital,Department of Infectious Diseases
[4] Copenhagen University Hospital,Departments of Medicine and Oncology, Herlev Hospital
[5] University of Copenhagen,undefined
来源：
BMC Pulmonary Medicine | / 13卷
关键词：
COPD; Inflammation; Mortality; Prognosis; YKL-40;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease
    Holmgaard, Dennis B.
    Mygind, Lone H.
    Titlestad, Ingrid L.
    Madsen, Hanne
    Pedersen, Svend Stenvang
    Johansen, Julia S.
    Pedersen, Court
    BMC PULMONARY MEDICINE, 2013, 13
  • [2] INCREASED LEVELS OF YKL-40 ARE ASSOCIATED WITH ALL-CAUSE MORTALITY IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE
    Herz, C. T.
    Tscharre, M. L.
    Hobaus, C.
    Pesau, G.
    Obendorf, F.
    Koppensteiner, R.
    Schernthaner, G. H.
    ATHEROSCLEROSIS, 2016, 252 : E67 - E68
  • [3] Serum YKL-40 concentration is associated with all-cause mortality in patients with congestive heart failure
    Harutyunyan, M.
    Christiansen, M.
    Johansen, J. S.
    Koeber, L.
    Petersen, C. H. Torp
    Kastrup, J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1047 - 1048
  • [4] Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease
    James, Anna J.
    Reinius, Lovisa E.
    Verhoek, Marri
    Gomes, Anna
    Kupczyk, Maciej
    Hammar, Ulf
    Ono, Junya
    Ohta, Shoichiro
    Izuhara, Kenji
    Bel, Elisabeth
    Kere, Juha
    Soderhall, Cilia
    Dahlen, Barbro
    Boot, Rolf G.
    Dahlen, Sven-Erik
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (02) : 131 - 142
  • [5] Association between serum YKL-40 and chronic obstructive pulmonary disease
    Ma, Yao
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [6] All-Cause Mortality In Aboriginal Peoples With Chronic Obstructive Pulmonary Disease
    Ospina, M. B.
    Rowe, B. H.
    Senthilselvan, A.
    Stickland, M. K.
    King, M.
    Voaklander, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [7] YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages
    Letuve, Severine
    Kozhich, Alexander
    Arouche, Nassim
    Grandsaigne, Martine
    Reed, Jennifer
    Dombret, Marie-Christine
    Kiener, Peter A.
    Aubier, Michel
    Coyle, Anthony J.
    Pretolani, Marina
    JOURNAL OF IMMUNOLOGY, 2008, 181 (07): : 5167 - 5173
  • [8] High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease
    Kastrup, Jens
    Johansen, Julia S.
    Winkel, Per
    Hansen, Jorgen Fischer
    Hildebrandt, Per
    Jensen, Gorm Boje
    Jespersen, Christian M.
    Kjoller, Erik
    Kolmos, Hans Jorn
    Lind, Inga
    Nielsen, Henrik
    Gluud, Christian
    EUROPEAN HEART JOURNAL, 2009, 30 (09) : 1066 - 1072
  • [9] THE ALL-CAUSE MORTALITY AND INFECTION RISKS IN HEMODIALYSIS PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Lin, Yi-Ting
    Wu, Ping-Hsun
    Kuo, Mei-Chuan
    Chen, Hung-Chun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [10] THE INFLAMMATORY BIOMARKER YKL-40 AS A NEW PROGNOSTIC MARKER FOR ALL-CAUSE MORTALITY IN PATIENTS WITH HEART FAILURE
    Harutyunyan, Marina
    Kober, Lars
    Johansen, Julia
    Torp-Pedersen, Christian
    Kastrup, Jens
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E942 - E942
12345